-
Something wrong with this record ?
Hemodialysis vascular access affects heart function and outcomes: Tips for choosing the right access for the individual patient
J. Malik, C. Lomonte, J. Rotmans, E. Chytilova, R. Roca-Tey, M. Kusztal, T. Grus, M. Gallieni
Language English Country United States
Document type Journal Article, Review
- MeSH
- Arteriovenous Fistula * MeSH
- Arteriovenous Shunt, Surgical * adverse effects MeSH
- Renal Insufficiency, Chronic * diagnosis therapy MeSH
- Kidney Failure, Chronic * MeSH
- Renal Dialysis MeSH
- Humans MeSH
- Ligation MeSH
- Kidney Transplantation * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Chronic kidney disease is associated with increased cardiovascular morbidity and mortality. A well-functioning vascular access is associated with improved survival and among the available types of vascular access the arterio-venous (AV) fistula is the one associated with the best outcomes. However, AV access may affect heart function and, in some patients, could worsen the clinical status. This review article focuses on the specific cardiovascular hemodynamics of dialysis patients and how it is affected by the AV access; the effects of an excessive increase in AV access flow, leading to high-output heart failure; congestive heart failure in CKD patients and the contraindications to AV access; pulmonary hypertension. In severe heart failure, peritoneal dialysis (PD) might be the better choice for cardiac health, but if contraindicated suggestions for vascular access selection are provided based on the individual clinical presentation. Management of the AV access after kidney transplantation is also addressed, considering the cardiovascular benefit of AV access ligation compared to the advantage of having a functioning AVF as backup in case of allograft failure. In PD patients, who need to switch to hemodialysis, vascular access should be created timely. The influence of AV access in patients undergoing cardiac surgery for valvular or ischemic heart disease is also addressed. Cardiovascular implantable electronic devices are increasingly implanted in dialysis patients, but when doing so, the type and location of vascular access should be considered.
Department of Internal Medicine Leiden University Medical Center Leiden The Netherlands
Department of Nephrology and Transplantation Medicine Wroclaw Medical University Wroclaw Poland
Department of Nephrology Hospital de Mollet Fundació Sanitària Mollet Barcelona Spain
Miulli General Hospital Division of Nephrology Acquaviva delle Fonti Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003336
- 003
- CZ-PrNML
- 005
- 20220127150328.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/1129729820969314 $2 doi
- 035 __
- $a (PubMed)33143540
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Malik, Jan $u Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 245 10
- $a Hemodialysis vascular access affects heart function and outcomes: Tips for choosing the right access for the individual patient / $c J. Malik, C. Lomonte, J. Rotmans, E. Chytilova, R. Roca-Tey, M. Kusztal, T. Grus, M. Gallieni
- 520 9_
- $a Chronic kidney disease is associated with increased cardiovascular morbidity and mortality. A well-functioning vascular access is associated with improved survival and among the available types of vascular access the arterio-venous (AV) fistula is the one associated with the best outcomes. However, AV access may affect heart function and, in some patients, could worsen the clinical status. This review article focuses on the specific cardiovascular hemodynamics of dialysis patients and how it is affected by the AV access; the effects of an excessive increase in AV access flow, leading to high-output heart failure; congestive heart failure in CKD patients and the contraindications to AV access; pulmonary hypertension. In severe heart failure, peritoneal dialysis (PD) might be the better choice for cardiac health, but if contraindicated suggestions for vascular access selection are provided based on the individual clinical presentation. Management of the AV access after kidney transplantation is also addressed, considering the cardiovascular benefit of AV access ligation compared to the advantage of having a functioning AVF as backup in case of allograft failure. In PD patients, who need to switch to hemodialysis, vascular access should be created timely. The influence of AV access in patients undergoing cardiac surgery for valvular or ischemic heart disease is also addressed. Cardiovascular implantable electronic devices are increasingly implanted in dialysis patients, but when doing so, the type and location of vascular access should be considered.
- 650 12
- $a arteriovenózní píštěl $7 D001164
- 650 12
- $a arteriovenózní zkrat $x škodlivé účinky $7 D001166
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chronické selhání ledvin $7 D007676
- 650 12
- $a transplantace ledvin $7 D016030
- 650 _2
- $a ligace $7 D008026
- 650 _2
- $a dialýza ledvin $7 D006435
- 650 12
- $a chronická renální insuficience $x diagnóza $x terapie $7 D051436
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Lomonte, Carlo $u Miulli General Hospital, Division of Nephrology, Acquaviva delle Fonti, Italy
- 700 1_
- $a Rotmans, Joris $u Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
- 700 1_
- $a Chytilova, Eva $u Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Roca-Tey, Ramon $u Department of Nephrology, Hospital de Mollet, Fundació Sanitària Mollet, Barcelona, Spain
- 700 1_
- $a Kusztal, Mariusz $u Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland
- 700 1_
- $a Grus, Tomas $u Second Department of Surgery, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Gallieni, Maurizio $u Nephrology and Dialysis Unit - ASST Fatebenefratelli Sacco, Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milano, Milano, Italy
- 773 0_
- $w MED00181745 $t The journal of vascular access $x 1724-6032 $g Roč. 22, č. 1_suppl (2021), s. 32-41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33143540 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150324 $b ABA008
- 999 __
- $a ok $b bmc $g 1750952 $s 1154485
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 22 $c 1_suppl $d 32-41 $e 20201104 $i 1724-6032 $m The journal of vascular access $n J Vasc Access $x MED00181745
- LZP __
- $a Pubmed-20220113